Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 21:13:900091.
doi: 10.3389/fimmu.2022.900091. eCollection 2022.

Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021)

Brahim Belaid  1 Lydia Lamara Mahammed  1 Ouardia Drali  2 Aida Mohand Oussaid  3 Nabila Souad Touri  4 Souhila Melzi  5 Abdelhak Dehimi  6 Lylia Meriem Berkani  1 Fatma Merah  7 Zineb Larab  7 Ines Allam  1 Ouarda Khemici  8 Sonya Yasmine Kirane  9 Mounia Boutaba  10 Reda Belbouab  11 Hadjira Bekkakcha  10 Assia Guedouar  10 Abdelhakim Chelali  12 Brahim Baamara  12 Djamila Noui  13 Hadda Baaziz  13 Radia Rezak  14 Sidi Mohamed Azzouz  15 Malika Aichaoui  16 Assia Moktefi  16 Redha Mohamed Benhatchi  16 Meriem Oussalah  17 Naila Benaissa  18 Amel Laredj  18 Assia Bouchetara  18 Abdelkader Adria  19 Brahim Habireche  20 Noureddine Tounsi  20 Fella Dahmoun  21 Rabah Touati  21 Hamza Boucenna  3 Fadila Bouferoua  3 Lynda Sekfali  3 Nadjet Bouhafs  5 Rawda Aboura  5 Sakina Kherra  10 Yacine Inouri  22 Saadeddine Dib  23 Nawel Medouri  24 Noureddine Khelfaoui  24 Aicha Redjedal  24 Amara Zelaci  25 Samah Yahiaoui  26 Sihem Medjadj  27 Tahar Khelifi Touhami  28 Ahmed Kadi  29 Fouzia Amireche  30 Imane Frada  31 Shahrazed Houasnia  32 Karima Benarab  33 Chahynez Boubidi  10 Yacine Ferhani  11 Hayet Benalioua  11 Samia Sokhal  11 Nadia Benamar  34 Samira Aggoune  35 Karima Hadji  36 Asma Bellouti  37 Hakim Rahmoune  6 Nada Boutrid  6 Kamelia Okka  6 Assia Ammour  38 Houssem Saadoune  39 Malika Amroun  22 Hayet Belhadj  22 Amina Ghanem  40 Hanane Abbaz  40 Sana Boudrioua  41 Besma Zebiche  42 Assia Ayad  42 Zahra Hamadache  42 Nassima Ouaras  43 Nassima Achour  43 Nadira Bouchair  44 Houda Boudiaf  45 Dahila Bekkat-Berkani  46 Hachemi Maouche  35 Zahir Bouzrar  5 Lynda Aissat  47 Ouardia Ibsaine  48 Belkacem Bioud  6 Leila Kedji  4 Djazia Dahlouk  22 Manoubia Bensmina  49 Abdelkarim Radoui  17 Mimouna Bessahraoui  15 Nadia Bensaadi  33 Azzeddine Mekki  2 Zoulikha Zeroual  10 Koon-Wing Chan  50 Daniel Leung  50 Amar Tebaibia  51 Soraya Ayoub  52 Dalila Mekideche  53 Merzak Gharnaout  29 Jean Laurent Casanova  54   55   56   57 Anne Puel  54   55   56 Yu Lung Lau  50 Nacira Cherif  9 Samir Ladj  58 Leila Smati  46 Rachida Boukari  11 Nafissa Benhalla  3 Reda Djidjik  1
Affiliations

Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021)

Brahim Belaid et al. Front Immunol. .

Abstract

Background: Inborn errors of immunity (IEI) predispose patients to various infectious and non-infectious complications. Thanks to the development and expanding use of flow cytometry and increased awareness, the diagnostic rate of IEI has markedly increased in Algeria the last decade.

Aim: This study aimed to describe a large cohort of Algerian patients with probable IEI and to determine their clinical characteristics and outcomes.

Methods: We collected and analyzed retrospectively the demographic data, clinical manifestations, immunologic, genetic data, and outcome of Algerian IEI patients - diagnosed in the department of medical immunology of Beni Messous university hospital center, Algiers, from 2008 to 2021.

Results: Eight hundred and seven patients with IEI (482 males and 325 females) were enrolled, 9.7% of whom were adults. Consanguinity was reported in 50.3% of the cases and a positive family history in 32.34%. The medium age at disease onset was 8 months and at diagnosis was 36 months. The median delay in diagnosis was 16 months. Combined immunodeficiencies were the most frequent (33.8%), followed by antibody deficiencies (24.5%) and well-defined syndromes with immunodeficiency (24%). Among 287 patients tested for genetic disorders, 129 patients carried pathogenic mutations; 102 having biallelic variants mostly in a homozygous state (autosomal recessive disorders). The highest mortality rate was observed in patients with combined immunodeficiency (70.1%), especially in patients with severe combined immunodeficiency (SCID), Omenn syndrome, or Major Histocompatibility Complex (MHC) class II deficiency.

Conclusion: The spectrum of IEI in Algeria is similar to that seen in most countries of the Middle East and North Africa (MENA) region, notably regarding the frequency of autosomal recessive and/or combined immunodeficiencies.

Keywords: Algeria; clinical features; diagnosis; epidemiology; inborn errors of immunity; molecular diagnosis; primary immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Distribution of the frequencies of IEIs according to IUIS categories in 807 Algerian patients in the study. IEI groups are shown according to IUIS classification, 2021. Total number of patients and percentage of all registered patients are shown for each group. AGAM, agammaglobulinemia; ALPS, autoimmune lymphoproliferative syndrome; AID, autoinflammatory diseases; A-T, ataxia- telangiectasia; c, classified; CD, complement deficiencies; CF, cystic fibrosis; CGD, chronic granulomatous disease; CID, combined immunodeficiencies; CVID, common variable immunodeficiency; DGS, DiGeorge syndrome, DID, Dysregulation of immune diseases; f-HLH, familial Hemophagocytic lymphohistiocytosis; GS, good syndrome; HIES, hyper-IgE syndrome; HIDS, hyper-IgD syndrome; IID, innate immune deficiencies; MSMD, mendelian susceptibility to mycobacterial disease; PAD, predominantly antibody deficiencies; PD, phagocytic deficiencies; SCN, severe congenital neutropenia; sIgA; selective IgA deficiency; SP, Somatic phenocopies; SynCID, syndromic combined immunodeficiencies; u, unclassified; WAS, Wiskott Aldrich syndrome; XLT, X linked thrombocytopenia.
Figure 2
Figure 2
Distribution of patients according to IEI diagnosis age groups and main IEI categories (N = 807).
Figure 3
Figure 3
The median age of disease onset and diagnostic delay in the main IEI categories. (A) Median age of disease onset. (B) Median of diagnostic delay.
Figure 4
Figure 4
Annual numbers of newly diagnosed IEI cases from 2008 to September 2021. The registration of patients into the database has been stopped in September for the year 2021.
Figure 5
Figure 5
distribution of patients in the different provinces of Algeria. The base map was created with the permission of data wrapper. The intensity of the blue color is proportional to the number of patients. The registered number includes living and deceased patients. Each number on the map corresponds to a province.
Figure 6
Figure 6
(A) Mortality rate by PID group and age of the deceased patients (n: 231). Colors represent different IEI categories. Numbers in the plots show the number of patients and the ratio of the deceased patients by IEI group to the total number of the deceased patients of the age-group; (B) Overall survival (Kaplan-Meier curve) of patients with IEI showing the probability of survival following diagnosis. (C) Kaplan-Meier curve showing overall survival in the 807 studied patients within the 9 categories of IEI. CID, combined immunodeficiencies; SyCID, syndromic combined immunodeficiencies; PAD, predominantly antibody deficiencies; DID, Dysregulation of immune diseases; PD, phagocytic disorders; CD, complement deficiencies; IID, innate immune deficiencies; AID, autoinflammatory diseases; SP, Somatic phenocopies.
Figure 7
Figure 7
Comparison of IEI death percentages in our cohort with previously published IEI studies of other countries. Algeria: green; European countries: red; Asian countries and regions: brown, north African countries: blue. Parentheses next to each country name correspond to number of patients followed by year of analysis (number of patients; year of analysis).

Similar articles

  • Algerian Registry for Inborn Errors of Immunity in Children: Report of 887 Children (1985-2021).
    Yagoubi A, Tahiat A, Touri NS, Ladj MS, Drali O, Belaid B, Mohand-Oussaid A, Dehimi A, Belbouab R, Ferhani Y, Melzi S, Guedouar A, Hakem S, Khemici O, Inouri Y, Meddour Y, Dib S, Mansouri Z, Iddir S, Boufersaoui A, Boudiaf H, Bouhdjila A, Ibsaine O, Maouche H, Dahlouk D, Mekki A, Bioud B, Bouzerar Z, Zeroual Z, Benhassine F, Bekkat-Berkani D, Naamoune S, Salah SS, Chaib S, Attal N, Bensaadi N, Bouchair N, Cherif N, Kedji L, Bendeddouche S, Atif ML, Djenouhat K, Kechout N, Djidjik R, Benhalla KN, Smati L, Boukari R. Yagoubi A, et al. J Clin Immunol. 2022 Nov;42(8):1660-1671. doi: 10.1007/s10875-022-01330-5. Epub 2022 Jul 15. J Clin Immunol. 2022. PMID: 35838820
  • Consensus Middle East and North Africa Registry on Inborn Errors of Immunity.
    Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, Ozen A, Baris S, Karakoc-Aydiner E, Kilic SS, Kose H, Gulez N, Genel F, Reisli I, Djenouhat K, Tahiat A, Boukari R, Ladj S, Belbouab R, Ferhani Y, Belaid B, Djidjik R, Kechout N, Attal N, Saidani K, Barbouche R, Bousfiha A, Sobh A, Rizk R, Elnagdy MH, Al-Ahmed M, Al-Tamemi S, Nasrullayeva G, Adeli M, Al-Nesf M, Hassen A, Mehawej C, Irani C, Megarbane A, Quinn J; MENA-I. E. I. Study Group; Maródi L, Modell V, Modell F, Al-Herz W, Geha RS, Abolhassani H. Aghamohammadi A, et al. J Clin Immunol. 2021 Aug;41(6):1339-1351. doi: 10.1007/s10875-021-01053-z. Epub 2021 May 29. J Clin Immunol. 2021. PMID: 34052995 Free PMC article.
  • Immune Dysregulation in Monogenic Inborn Errors of Immunity in Oman: Over A Decade of Experience From a Single Tertiary Center.
    Al Farsi T, Ahmed K, Alshekaili J, Al Kindi M, Cook M, Al-Hosni A, Ansari Z, Nasr I, Al Sukaiti N. Al Farsi T, et al. Front Immunol. 2022 Apr 6;13:849694. doi: 10.3389/fimmu.2022.849694. eCollection 2022. Front Immunol. 2022. PMID: 35464432 Free PMC article.
  • The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity.
    Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, Reisli I, Tahiat A, Shendi HM, Elaziz DA, Belaid B, Al Dhaheri F, Haskologlu S, Dogu F, Ben-Mustapha I, Sobh A, Galal N, Meshaal S, Elhawary R, El-Marsafy A, Alroqi FJ, Al-Saud B, Al-Ahmad M, Al Farsi T, Al Sukaiti N, Al-Tamemi S, Mehawej C, Dbaibo G, ElGhazali G, Kilic SS, Genel F, Kiykim A, Musabak U, Artac H, Guner SN, Boukari R, Djidjik R, Kechout N, Cagdas D, El-Sayed ZA, Karakoc-Aydiner E, Alzyoud R, Barbouche MR, Adeli M, Wakim RH, Reda SM, Ikinciogullari A, Ozen A, Bousfiha A, Al-Mousa H, Rezaei N, Al-Herz W, Geha RS. Baris S, et al. J Allergy Clin Immunol Pract. 2023 Jan;11(1):158-180.e11. doi: 10.1016/j.jaip.2022.10.003. Epub 2022 Oct 17. J Allergy Clin Immunol Pract. 2023. PMID: 36265766 Review.
  • Future of Therapy for Inborn Errors of Immunity.
    Perez E. Perez E. Clin Rev Allergy Immunol. 2022 Aug;63(1):75-89. doi: 10.1007/s12016-021-08916-8. Epub 2022 Jan 12. Clin Rev Allergy Immunol. 2022. PMID: 35020169 Free PMC article. Review.

Cited by

References

    1. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. . Human Inborn Errors of Immunity: 2019 Update on the Classification From the International Union of Immunological Societies Expert Committee. J Clin Immunol (2020) 40:24–64. doi: 10.1007/s10875-019-00737-x - DOI - PMC - PubMed
    1. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. . Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol (2020) 40:66–81. doi: 10.1007/s10875-020-00758-x - DOI - PMC - PubMed
    1. Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. . The Ever-Increasing Array of Novel Inborn Errors of Immunity: An Interim Update by the IUIS Committee. J Clin Immunol (2021) 41:666–79. doi: 10.1007/s10875-021-00980-1 - DOI
    1. Notarangelo LD, Bacchetta R, Casanova JL, Su HC. Human Inborn Errors of Immunity: An Expanding Universe. Sci Immunol (2020) 5:eabb1662. doi: 10.1126/sciimmunol.abb1662 - DOI - PMC - PubMed
    1. Notarangelo LD. Primary Immunodeficiencies. J Allergy Clin Immunol (2010) 125:S182–94. doi: 10.1016/j.jaci.2009.07.053 - DOI

Publication types